BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32528904)

  • 1. Clinical Proteomics Profiling for Biomarker Identification Among Patients Suffering With Indian Post Kala Azar Dermal Leishmaniasis.
    Jaiswal P; Ghosh M; Patra G; Saha B; Mukhopadhyay S
    Front Cell Infect Microbiol; 2020; 10():251. PubMed ID: 32528904
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycoproteins in circulating immune complexes are biomarkers of patients with Indian PKDL: A study from endemic districts of West Bengal, India.
    Jaiswal P; Datta S; Sardar B; Chaudhuri SJ; Maji D; Ghosh M; Saha B; Mukhopadhyay S
    PLoS One; 2018; 13(2):e0192302. PubMed ID: 29420575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An In-depth Proteomic Map of Leishmania donovani Isolate from Post Kala-azar Dermal Leishmaniasis (PKDL) Patient.
    Routaray CB; Kumar A; Sundar S; Sathe G; Pawar H; Pai K
    Acta Parasitol; 2022 Jun; 67(2):687-696. PubMed ID: 35020128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.
    Saha S; Mazumdar T; Anam K; Ravindran R; Bairagi B; Saha B; Goswami R; Pramanik N; Guha SK; Kar S; Banerjee D; Ali N
    J Clin Microbiol; 2005 Mar; 43(3):1269-77. PubMed ID: 15750095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of anti-gal enzyme-linked immunosorbent assay for the diagnosis of Indian post-kala-azar dermal leishmaniasis.
    Datta S; Ghosh M; Sarkar S; Saha B; Mukhopadhyay S
    Indian J Dermatol Venereol Leprol; 2019; 85(6):578-589. PubMed ID: 31397399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post-kala-azar dermal leishmaniasis (PKDL) patients.
    Owen SI; Hossain F; Ghosh P; Chowdhury R; Hossain MS; Jewell C; Cruz I; Picado A; Mondal D; Adams ER
    Parasit Vectors; 2021 Feb; 14(1):111. PubMed ID: 33597000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Recombinase Polymerase Amplification assay for monitoring parasite load in patients with kala-azar and post kala-azar dermal leishmaniasis.
    Roy M; Ceruti A; Kobialka RM; Roy S; Sarkar D; Wahed AAE; Chatterjee M
    PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011231. PubMed ID: 37075066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis.
    Marlais T; Bhattacharyya T; Singh OP; Mertens P; Gilleman Q; Thunissen C; Hinckel BCB; Pearson C; Gardner BL; Airs S; de la Roche M; Hayes K; Hafezi H; Falconar AK; Eisa O; Saad A; Khanal B; Bhattarai NR; Rijal S; Boelaert M; El-Safi S; Sundar S; Miles MA
    Front Cell Infect Microbiol; 2018; 8():427. PubMed ID: 30619774
    [No Abstract]   [Full Text] [Related]  

  • 9. Real-Time Fluorimetry Loop-Mediated Isothermal Amplification for Diagnosis of Leishmaniasis and as a Tool for Assessment of Cure for Post-Kala-Azar Dermal Leishmaniasis.
    Dixit KK; Ramesh V; Gupta R; Negi NS; Singh R; Salotra P
    Am J Trop Med Hyg; 2021 Apr; 104(6):2097-2107. PubMed ID: 33872204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand Flies.
    Mondal D; Bern C; Ghosh D; Rashid M; Molina R; Chowdhury R; Nath R; Ghosh P; Chapman LAC; Alim A; Bilbe G; Alvar J
    Clin Infect Dis; 2019 Jul; 69(2):251-258. PubMed ID: 30357373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.
    Kaushal H; Bras-Gonçalves R; Avishek K; Kumar Deep D; Petitdidier E; Lemesre JL; Papierok G; Kumar S; Ramesh V; Salotra P
    Clin Exp Immunol; 2016 Jul; 185(1):50-60. PubMed ID: 26948150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of blood based quantitative PCR as a molecular diagnostic tool for post kala-azar dermal leishmaniasis (PKDL).
    Kumar A; Singh VK; Madhukar P; Tiwari R; Roy R; Rajneesh ; Mehrotra S; Sundar S; Kumar R
    Mol Biol Rep; 2024 Jun; 51(1):716. PubMed ID: 38824237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India.
    Ejazi SA; Bhattacharya P; Bakhteyar MA; Mumtaz AA; Pandey K; Das VN; Das P; Rahaman M; Goswami RP; Ali N
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005035. PubMed ID: 27741241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.
    Sarraf NR; Mukhopadhyay S; Banerjee A; Das AK; Roy S; Chakrabarti S; Manna M; Saha P
    Acta Trop; 2021 Nov; 223():106086. PubMed ID: 34389331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCR-based detection of Leishmania DNA in skin samples of post kala-azar dermal leishmaniasis patients from an endemic area of Bangladesh.
    Nasreen SA; Hossain MA; Paul SK; Mahmud MC; Ahmed S; Ghosh S; Kobayashi N
    Jpn J Infect Dis; 2012 Jul; 65(4):315-7. PubMed ID: 22814154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Blood as the Clinical Specimen for the Molecular Diagnosis of Post-Kala-Azar Dermal Leishmaniasis.
    Dixit KK; Ramesh V; Upadhyay S; Singh AK; Singh OP; Sundar S; Singh R; Salotra P
    J Clin Microbiol; 2021 Aug; 59(9):e0013221. PubMed ID: 34160275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
    Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting the role of the slit-skin smear in the diagnosis of Indian post-kala-azar dermal leishmaniasis.
    Bhargava A; Ramesh V; Verma S; Salotra P; Bala M
    Indian J Dermatol Venereol Leprol; 2018; 84(6):690-695. PubMed ID: 30058565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome Analysis of Dermal Fibroblasts Derived From Visceral Leishmaniasis and Post-Kala-Azar Dermal Leishmaniasis Patients Reveal Disease-Specific Gene Expression and Pathological Regulation.
    Singh S; Madhukar M; Dikhit MR; Ravidas VN; Pandey K; Sen A
    J Infect Dis; 2023 May; 227(10):1132-1142. PubMed ID: 36821723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active surveillance identified a neglected burden of macular cases of Post Kala-azar Dermal Leishmaniasis in West Bengal.
    Sengupta R; Chaudhuri SJ; Moulik S; Ghosh MK; Saha B; Das NK; Chatterjee M
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007249. PubMed ID: 30856178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.